Negev Capital logo

Negev Capital

North America, Midland, Cayman Islands, Grand Cayman

Description

Negev Capital primarily target psychedelic companies with interventions that are at early-mid stages of clinical development.

Investor Profile

Negev Capital has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Seed (38%)
  • Series B (25%)
  • Series A (25%)
  • Post Ipo Equity (13%)

Country Focus

  • United States (75%)
  • United Kingdom (13%)
  • Australia (13%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Alternative Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Negev Capital frequently co-invest with?

Ambria Capital
North America, NA - Puerto Rico, Puerto Rico, San Juan
Co-Investments: 2
Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 2
K2 & Associates
North America, Ontario, Canada, Toronto
Co-Investments: 2
JLS Fund
North America, New York, United States, New York
Co-Investments: 2
Day One Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Prime Movers Lab
North America, Wyoming, United States, Jackson
Co-Investments: 2
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Ayuh Ventures
North America, Delaware, United States, Dover
Co-Investments: 3
PS
North America, Illinois, United States, Highland Park
Co-Investments: 3
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 3

Which angels does Negev Capital often collaborate with?

AM
North America, California, United States, San Francisco
Shared Deals: 1
VH
North America, New York, United States, New York
Shared Deals: 1
GS
North America, Indiana, United States, Indianapolis
Shared Deals: 1
RH
Europe, Ile-de-France, France, Paris
Shared Deals: 1
JT
North America, Georgia, United States, Atlanta
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
MH
North America, California, United States, San Francisco
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Negev Capital?

Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BDec 15, 2022
Amount Raised: $39,000,000
Psylo

Sydney, New South Wales, Australia

Psylo is a drug development company that focuses on next-generation psychedelics.

Biotechnology
SeedOct 27, 2022
Amount Raised: $3,225,276
Reset Pharmaceuticals

New York, New York, United States

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

BiotechnologyHealth CareMedical
Series AFeb 16, 2022
Amount Raised: $11,100,000
Mindstate Design Labs

Pittsburgh, Pennsylvania, United States

Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.

BiotechnologyHealth CareTherapeutics
SeedFeb 10, 2022
Amount Raised: $11,500,000
Delix Therapeutics

Boston, Massachusetts, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

BiotechnologyHealth CareLife Science
Series ASep 27, 2021
Amount Raised: $70,000,000
MycroDose Therapeutics

San Diego, California, United States

Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems

Health CarePharmaceutical
SeedSep 21, 2021
Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Series BAug 15, 2021
Amount Raised: $80,404,797
WeSana Health

Homer Glen, Illinois, United States

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine.

Alternative MedicineHealth CareTherapeutics
Post Ipo EquityMar 31, 2021
Amount Raised: $12,813,472